Clinical Masks of Diabetic Neuropathy
Diabetes mellitus (DM) is a widespread chronic disease in which a wide range of various pathological processes are observed in a number of organs and systems of the body as a result of metabolic disorders caused by hyperglycemia. Diabetic neuropathy is the most common complication of DM. e epidemic increase in the incidence of DM along with the late diagnosis of its complications, in particular, diabetic neuropathy, leads to early maladaptation, a signi cant decrease in the quality of life and disability of these patients. Damage to the peripheral nervous system can occur latently or have a variety of clinical masks that do not allow clinicians to detect diabetic neuropathy in time and use pathogenetically based drugs in time in accordance with the level of evidence of the available recommendations - α-lipoic or thioctic acid, which is strategically important in treatment of patients with DM, especially patients with longer recovery and especially with a relapsing course of diabetic neuron patii.